Paul Allegakoen

2 articles listing Paul Allegakoen in Nature Communications, indexed by Paperzzz from Crossref and OSF.

1. Pan-RAF inhibitor exarafenib targets BRAF class II/III NSCLC and reveals ARAF-KSR1 resistance and combination strategies Nature Communications
2. Bladder cancer variants share aggressive features including a CA125+ cell state and targetable TM4SF1 expression Nature Communications